Teva Pharmaceutical Industries (TEVA) Free Cash Flow: 2009-2025
Historic Free Cash Flow for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $233.0 million.
- Teva Pharmaceutical Industries' Free Cash Flow fell 57.25% to $233.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $578.0 million, marking a year-over-year decrease of 57.75%. This contributed to the annual value of $749.0 million for FY2024, which is 11.05% down from last year.
- According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Free Cash Flow is $233.0 million, which was up 77.86% from $131.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Free Cash Flow ranged from a high of $1.1 billion in Q4 2023 and a low of -$555.0 million during Q1 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Free Cash Flow had a median value of $131.0 million in 2025 and averaged $156.6 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Free Cash Flow tumbled by 413.56% in 2021 and then surged by 5,225.00% in 2023.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Free Cash Flow stood at $303.0 million in 2021, then soared by 174.26% to $831.0 million in 2022, then climbed by 28.16% to $1.1 billion in 2023, then slumped by 58.12% to $446.0 million in 2024, then plummeted by 57.25% to $233.0 million in 2025.
- Its last three reported values are $233.0 million in Q3 2025, $131.0 million for Q2 2025, and -$232.0 million during Q1 2025.